Literature DB >> 938022

Concentrations of gentamicin and amikacin in human kidneys.

C Q Edwards, C R Smith, K L Baughman, J F Rogers, P S Lietman.   

Abstract

High kidney concentrations of gentamicin or amikacin, measured by an enzymological assay, were found in 9 of 10 patients who died during therapy with these aminoglycosides. Renal cortical concentrations of gentamicin ranged from 140 to 540 mug/g of tissue, with medullary levels of 128 to 230 mug/g. Concentrations of amikacin ranged from 365 to 1,030 mug/g in the cortex and from 270 to 718 mug/g in the medulla. The only patient with low kidney concentrations was an infant who received a single dose of gentamicin. Tissue levels were high in patients with both normal and abnormal renal function. Our results indicate that gentamicin and amikacin are concentrated in renal cortical and medullary tissue.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938022      PMCID: PMC429652          DOI: 10.1128/AAC.9.6.925

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Experimental aminoglycoside nephrotoxicity.

Authors:  F C Luft; V Patel; M N Yum; B Patel; S A Kleit
Journal:  J Lab Clin Med       Date:  1975-08

2.  Therapeutic implications of gentamicin accumulation in severly diseased kidneys.

Authors:  A Whelton; G G Carter; H H Bryant; L Fox; W G Walker
Journal:  Arch Intern Med       Date:  1976-02

3.  Enzymatic acetylation as a means of determining serum aminoglycoside concentrations.

Authors:  M J Haas; J Davies
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

  3 in total
  20 in total

1.  Effect of N'-methylnicotinamide on the renal accumulation and reabsorption of gentamicin in rats.

Authors:  R Jerauld; F J Silverblatt
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

2.  Distribution of gentamicin and amikacin in rabbit tissues.

Authors:  M L Kornguth; C M Kunin
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 4.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

5.  The effect of dietary protein restriction on high dose gentamicin nephrotoxicity in rats.

Authors:  P H Whiting; D A Power; J Petersen; A Innes; J G Simpson; G R Catto
Journal:  Br J Exp Pathol       Date:  1988-02

6.  Pharmacokinetics of gentamicin in very low birth weight preterm infants.

Authors:  K W Hindmarsh; R L Nation; G L Williams; E John; J N French
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.

Authors:  M A French; F B Cerra; M E Plaut; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 8.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

9.  Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling.

Authors:  D Beauchamp; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children.

Authors:  A Viganò; N Principi; L Brivio; P Tommasi; P Stasi; A D Villa
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.